RNF5 and cystic fibrosis: However, unlike SORDD1, which suppressed Rh1G69D–associated retinal degeneration, genetic and pharmacological inhibition of RNF5 in vivo attenuates intestinal pathological phenotypes in a mouse model of cystic fibrosis without blocking degradation of CFTRΔF508 [48, 49].